Evidence map›Paper›PMID 29557072›Full record

ArticleClinical rheumatology2018

Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.

Cemile Sonmez, Aysegul Atak Yucel, Turan Hilmi Yesil, Hamit Kucuk, Berna Sezgin, Ridvan Mercan, Ahmet Eftal Yucel, Gulderen Yanikkaya Demirel

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Behçet's Disease: A Comprehensive Review on the Role ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. CD4International journal of molecular sciences · 2021
    Review
  8. Frontiers in immunology · 2021
    Article
  9. Article
  10. Article
  11. Immunopathogenesis of Behcet's Disease.Frontiers in immunology · 2019
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cemile SonmezGazi University, Faculty of Medicine, Department of Immunology, Ankara, Turkey. cemilesonmez2004@yahoo.com.
Aysegul Atak YucelGazi University, Faculty of Medicine, Department of Immunology, Ankara, Turkey.
Turan Hilmi YesilBaşkent University, Faculty of Medicine, Department of Internal Medicine, Section of Rheumatology, Ankara, Turkey.
Hamit KucukGazi University, Faculty of Medicine, Department of Internal Medicine, Section of Rheumatology, Ankara, Turkey.
Berna SezginPublic Health Institution of Turkey, Department of Early Warning-Response and Field Epidemiology, Ankara, Turkey.
Ridvan MercanGazi University, Faculty of Medicine, Department of Internal Medicine, Section of Rheumatology, Ankara, Turkey.
Ahmet Eftal YucelBaşkent University, Faculty of Medicine, Department of Internal Medicine, Section of Rheumatology, Ankara, Turkey.
Gulderen Yanikkaya DemirelYeditepe University, Faculty of Medicine, Department of Immunology, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Behcet's disease is a chronic multisystemic disease with remissions and relapses. Several studies have shown that immune mechanisms play an important role in the development of the disease. In order to assess the association of disease activity with IL-17A/F, IL-23, IL-12/23 (p40) and IL-35 expression, we aimed to investigate production of these cytokines in peripheral blood mononuclear cells (PBMCs) from Behcet's patients and normal controls. Furthermore, we included Systemic Lupus Erythematosus (SLE) as disease control to evaluate the specificity of our data for immunopathogenesis of BD. Totally 15 active, 15 inactive Behcet's patients, 12 active and 12 inactive SLE patients and 12 healthy volunteers were enrolled in the study. Peripheral blood mononuclear cells were separated, lymphocyte cultures were performed and IL-17A/F, IL-12/23 p(40), IL-23, IL-35 cytokine levels were measured by ELISA in culture supernatants in the presence or absence of phytohemagglutinin (PHA) on time-dependent manner. IL-17 A/F levels increased parallel to IL-23 levels in Behcet's and SLE patients. Compared to healthy controls, IL-17 A/F levels were higher in active Behcet's and SLE patients; on the contrary, levels of IL-35 were lower. IL-17A/F, IL-12/23 (p40) and IL-23 levels were detectable most frequently in active Behcet's patients followed by active SLE patients. Our results indicate that IL-17 A/F, IL-23 and IL-12/23 (p40) may play role in the immunopathogenesis of BD so as Th17 and Th1 cell responses. Since IL-35 levels were lower in active Behcet's patients compared to inactive patients and healthy controls, there may be a plasticity between Th17 and Treg cells according to the state of disease activity.

Indexed as

AdultBehcet SyndromeCase-Control StudiesFemaleHumansInterleukin-12Interleukin-17Interleukin-23InterleukinsLeukocytes, MononuclearLymphocytesMaleMiddle AgedYoung AdultIL17A protein, humanIL17F protein, humanInterleukin-12Interleukin-17Interleukin-23interleukin-35, humanInterleukinsBehcet’s diseaseCytokineLymphocyte

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.